SOAT1 and metabolic dysfunction-associated steatotic liver disease: Our results indicate that SOAT1 promotes EMT in HCC through maintaining cholesterol homeostasis and therapeutic efficacy of nootkatone on NAFLD-HCC, which supports the critical role of the metabolic microenvironment in HCC metastasis, providing a new insight for the precision therapy on HCC.